Citadel Advisors’s G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 GSQB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-99,724
Closed -$10K 15738
2022
Q3
$10K Buy
99,724
+100
+0.1% +$14 ﹤0.01% 12287
2022
Q2
$13K Sell
99,624
-302,539
-75% -$79.3K ﹤0.01% 12533
2022
Q1
$113K Buy
402,163
+76,752
+24% +$35.8K ﹤0.01% 12160
2021
Q4
$195K Buy
+325,411
New +$241K ﹤0.01% 11888

Other funds holding GSQB.WS

Citadel Advisors's GSQB.WS Position: Q4 2022 in Review

Citadel Advisors sold out of G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (GSQB.WS) in Q4 2022, closing a stake of 99,724 shares — an estimated $10K sold.

Citadel Advisors first reported a position in GSQB.WS in Q4 2021 and held it in 4 quarters. The position peaked at $195K in Q4 2021. 29 funds tracked by Wall St. Rank hold GSQB.WS as of Q4 2022.

  • Citadel Advisors reported no remaining G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 99,724 G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $10K.
  • Citadel Advisors first reported a position in G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 4 quarters.
  • Citadel Advisors's G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $195K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.